Co-Existing Pediatric Ureteropelvic Junction Obstruction and Vesicoureteric Reflux: Prevalence and Implications
- PMID: 31105396
- PMCID: PMC6417044
- DOI: 10.4103/jiaps.JIAPS_37_18
Co-Existing Pediatric Ureteropelvic Junction Obstruction and Vesicoureteric Reflux: Prevalence and Implications
Abstract
Purpose: The purpose of this study is to ascertain the coexistence of ipsilateral vesicoureteric reflux (VUR) with ureteropelvic junction obstruction (UPJO) and to compare postpyeloplasty outcome in patients with and without associated VUR.
Materials and methods: Prospective study from 2014 to 2016 of consecutive children (n = 135) undergoing pyeloplasty. Data of patients without (Group 1) and with (Group 2) associated ipsilateral VUR were compared.
Results: Thirty-five patients (25.9%) had ipsilateral VUR along with UPJO (Group 2). This group showed the following unique features: (1) Higher percentage of infants (31/35) compared to Group 1 (62/100) (P = 0.003) (2) VUR in the contralateral (normal) kidney in 21/35 (60%) cases and nil in Group 1 (3) Significantly less preoperative differential renal function in children above 1 year (P = 0.007) (4) Presence of renal scars (18 units) and pyelonephritic changes (6 units) in Group 2 at the 1-year follow-up dimercaptosuccinic acid renal scan. Both groups showed improvement in function 3 months after pyeloplasty with no statistically significant difference. Improvement in drainage on the renal scan was better in Group 1 at 3 months postoperative (P = 0.015) as well as between 3 months and 1-year follow-up (P = 0.052).
Conclusion: The prevalence of VUR was 25.9% in this study and 33.3% in ≤1 year age group. There was a loss of function in delayed presenters with associated ipsilateral VUR. There was delayed drainage postpyeloplasty in patients with VUR. A preoperative voiding cystourethrogram should be done in children <1 year age before pyeloplasty so that associated VUR if detected can be concurrently managed along with pyeloplasty and preserve nephrons affected by the dual pathology.
Keywords: Ipsilateral; outcome; pediatric; pyeloplasty; ureteropelvic junction obstruction; vesicoureteric reflux.
Conflict of interest statement
There are no conflicts of interest.
Figures

References
-
- Hollowell JG, Altman HG, Snyder HM, 3rd, Duckett JW. Coexisting ureteropelvic junction obstruction and vesicoureteral reflux: Diagnostic and therapeutic implications. J Urol. 1989;142:490–3. - PubMed
-
- Maizels M, Smith CK, Firlit CF. The management of children with vesicoureteral reflux and ureteropelvic junction obstruction. J Urol. 1984;131:722–7. - PubMed
-
- Bomalaski MD, Hirschl RB, Bloom DA. Vesicoureteral reflux and ureteropelvic junction obstruction: Association, treatment options and outcome. J Urol. 1997;157:969–74. - PubMed
-
- Kim YS, Do SH, Hong CH, Kim MJ, Choi SK, Han SW, et al. Does every patient with ureteropelvic junction obstruction need voiding cystourethrography? J Urol. 2001;165:2305–7. - PubMed
-
- Estrada CR, Peters CA, Retik AB, Nguyen HT. Vesicoureteral reflux and urinary tract infection in children with a history of prenatal hydronephrosis – Should voiding cystourethrography be performed in cases of postnatally persistent grade II hydronephrosis? J Urol. 2009;181:801–6. - PubMed